Clinical trial
A National, Multi-center Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period
NCT02587195 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A National, Multi-center Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 18, 2015
- Completion date
- August 31, 2021
- Enrollment
- 5 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.